FN2 Earnings Intelligence
UnitedHealth Group Incorporated income statement (quarterly)
UnitedHealth Group Incorporated (UNH) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $32,400 | $30,717 | $28,596 | $27,210 | $28,001 |
| + Debt | $78,010 | $81,271 | $79,193 | $80,136 | $77,917 |
| Enterprise Value | - | - | - | - | - |
| Revenue | $100,820 | $109,575 | $111,616 | $113,161 | $111,721 |
| % Growth | - | - | - | - | - |
| Gross Profit | $88,986 | $97,185 | $98,597 | $100,595 | $98,898 |
| % Margin | 88.3% | 88.7% | 88.3% | 88.9% | 88.5% |
| EBITDA | $9,749 | $10,180 | $6,234 | $5,414 | $10,019 |
| % Margin | 9.7% | 9.3% | 5.6% | 4.8% | 9.0% |
| Net Income | $6,055 | $6,292 | $3,406 | $2,348 | $6,280 |
| % Margin | 6.0% | 5.7% | 3.1% | 2.1% | 5.6% |
| Diluted EPS | $6.51 | $6.85 | $3.74 | $2.59 | $6.90 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | - | $5,456 | - | - | $8,912 |
| CapEx | - | $898 | - | - | $763 |
| Free Cash Flow | - | $4,558 | - | - | $8,149 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue | $100,820 | $109,575 | $111,616 | $113,161 | $111,721 |
| Gross Profit | $88,986 | $97,185 | $98,597 | $100,595 | $98,898 |
| EBITDA | $9,749 | $10,180 | $6,234 | $5,414 | $10,019 |
| Net Income | $6,055 | $6,292 | $3,406 | $2,348 | $6,280 |
| Diluted EPS | $6.51 | $6.85 | $3.74 | $2.59 | $6.90 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $32,400 | $30,717 | $28,596 | $27,210 | $28,001 |
| Short-term Debt | $3,909 | $9,986 | $5,698 | $7,737 | $6,477 |
| Long-term Debt | $74,101 | $71,285 | $73,495 | $72,399 | $71,440 |
| Total Debt | $78,010 | $81,271 | $79,193 | $80,136 | $77,917 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $5,456 | - | - | $8,912 |
| Capital Expenditure | - | $898 | - | - | $763 |
| Free Cash Flow | - | $4,558 | - | - | $8,149 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 88.3% | 88.7% | 88.3% | 88.9% | 88.5% |
| EBITDA Margin | 9.7% | 9.3% | 5.6% | 4.8% | 9.0% |
| Net Margin | 6.0% | 5.7% | 3.1% | 2.1% | 5.6% |
| FCF Margin | - | 4.2% | - | - | 7.3% |
| Diluted EPS Growth | - | - | - | - | - |